{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:41:48Z","timestamp":1782891708260,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/04712-9"],"award-info":[{"award-number":["2018\/04712-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/04847-1"],"award-info":[{"award-number":["2018\/04847-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico, Brazil","doi-asserted-by":"crossref","award":["CNPq-308052\/2022-6"],"award-info":[{"award-number":["CNPq-308052\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71884-4","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T10:24:46Z","timestamp":1725963886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of germline variants in Brazilian pancreatic carcinoma patients"],"prefix":"10.1038","volume":"14","author":[{"given":"L\u00edvia Munhoz","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Maistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia Hirata","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Marques","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana Veronica Mendoza","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edia Filomena di Tullio","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Toledo","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Fridman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Adolpho de Menezes Pacheco","family":"Serio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Rodrigues Carvalho","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Antonio Senna","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderlei","family":"Segatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Pilar","family":"Estevez-Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Santa Cruz","family":"Guindalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulysses","family":"Ribeiro Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Azevedo Koike","family":"Folgueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"71884_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein, A. P. Pancreatic cancer epidemiology: Understanding the role of lifestyle and inherited risk factors. Nat. Rev. Gastroenterol. Hepatol. 18, 493\u2013502 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"71884_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/ijms23031205","volume":"23","author":"A Kasuga","year":"2022","unstructured":"Kasuga, A. et al. Molecular features and clinical management of hereditary pancreatic cancer syndromes and familial pancreatic cancer. Int. J. Mol. Sci. 23, 1205 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"71884_CR3","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1200\/JCO.20.03238","volume":"39","author":"R Casolino","year":"2021","unstructured":"Casolino, R. et al. Homologous recombination deficiency in pancreatic cancer: A systematic review and prevalence meta-analysis. J. Clin. Oncol. 39, 2617\u20132631 (2021).","journal-title":"J. Clin. Oncol."},{"key":"71884_CR4","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1038\/s41598-022-07383-1","volume":"12","author":"RSC Guindalini","year":"2022","unstructured":"Guindalini, R. S. C. et al. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. Sci. Rep. 12, 4190 (2022).","journal-title":"Sci. Rep."},{"key":"71884_CR5","unstructured":"Salzano, F. M. & Freire-Maia, N. Popula\u00e7\u00f5es Brasileiras: Aspectos Demograficos, Geneticos e Antropologicos (1967)."},{"key":"71884_CR6","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica\u2014IBGE. Censo Demogr\u00e1fico 2022 (IBGE, 2023)."},{"key":"71884_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017063","volume":"6","author":"SDJ Pena","year":"2011","unstructured":"Pena, S. D. J. et al. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS ONE 6, e17063 (2011).","journal-title":"PLoS ONE"},{"key":"71884_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1590\/1678-4685-gmb-2018-0076","volume":"42","author":"AM de Souza","year":"2019","unstructured":"de Souza, A. M., Resende, S. S., de Sousa, T. N. & de Brito, C. F. A. A systematic scoping review of the genetic ancestry of the Brazilian population. Genet. Mol. Biol. 42, 495\u2013508 (2019).","journal-title":"Genet. Mol. Biol."},{"key":"71884_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ajhg.2017.09.021","volume":"101","author":"C Fortes-Lima","year":"2017","unstructured":"Fortes-Lima, C. et al. Genome-wide ancestry and demographic history of African-descendant maroon communities from French Guiana and Suriname. Am. J. Hum. Genet. 101, 725\u2013736 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"71884_CR10","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/ijc.32525","volume":"146","author":"Z Du","year":"2020","unstructured":"Du, Z. et al. A genome-wide association study of prostate cancer in Latinos. Int. J. Cancer 146, 1819\u20131826 (2020).","journal-title":"Int. J. Cancer"},{"key":"71884_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00148","author":"H Khiabanian","year":"2018","unstructured":"Khiabanian, H. et al. Inference of germline mutational status and evaluation of loss of heterozygosity in high-depth. Tumor-only sequencing data. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/PO.17.00148 (2018).","journal-title":"JCO Precis. Oncol."},{"key":"71884_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103033","volume":"60","author":"K Mizukami","year":"2020","unstructured":"Mizukami, K. et al. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes. EBioMedicine 60, 103033 (2020).","journal-title":"EBioMedicine"},{"key":"71884_CR13","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000414","volume":"12","author":"PLS Uson","year":"2021","unstructured":"Uson, P. L. S. et al. Clinical impact of pathogenic germline variants in pancreatic cancer: Results from a multicenter, prospective, universal genetic testing study. Clin. Transl. Gastroenterol. 12, e00414 (2021).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"71884_CR14","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.3390\/cancers14184447","volume":"14","author":"A Puccini","year":"2022","unstructured":"Puccini, A. et al. Clinical significance of germline pathogenic variants among 51 cancer predisposition genes in an unselected cohort of Italian Pancreatic Cancer Patients. Cancers 14, 4447 (2022).","journal-title":"Cancers"},{"key":"71884_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2018.6228","volume":"319","author":"C Hu","year":"2018","unstructured":"Hu, C. et al. Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319, 2401 (2018).","journal-title":"JAMA"},{"key":"71884_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/jnci\/djy024","volume":"110","author":"MA Lowery","year":"2018","unstructured":"Lowery, M. A. et al. Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms. J. Natl. Cancer Inst. 110, 1067\u20131074 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"71884_CR17","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.3390\/cancers13174430","volume":"13","author":"G Wieme","year":"2021","unstructured":"Wieme, G. et al. Prevalence of germline pathogenic variants in cancer predisposing genes in Czech and Belgian pancreatic cancer patients. Cancers 13, 4430 (2021).","journal-title":"Cancers"},{"key":"71884_CR18","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","volume":"35","author":"K Shindo","year":"2017","unstructured":"Shindo, K. et al. Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J. Clin. Oncol. 35, 3382\u20133390 (2017).","journal-title":"J. Clin. Oncol."},{"key":"71884_CR19","doi-asserted-by":"publisher","first-page":"527e14","DOI":"10.1016\/j.jamcollsurg.2020.06.019","volume":"231","author":"H Hu","year":"2020","unstructured":"Hu, H. et al. Association of germline variants in human DNA damage repair genes and response to adjuvant chemotherapy in resected pancreatic ductal adenocarcinoma. J. Am. Coll. Surg. 231, 527e14-535e14 (2020).","journal-title":"J. Am. Coll. Surg."},{"key":"71884_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00291","author":"C Hu","year":"2018","unstructured":"Hu, C. et al. Multigene hereditary cancer panels reveal high-risk pancreatic cancer susceptibility genes. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/PO.17.00291 (2018).","journal-title":"JCO Precis. Oncol."},{"key":"71884_CR21","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","volume":"8","author":"BL Bychkovsky","year":"2022","unstructured":"Bychkovsky, B. L. et al. Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care\u2014Checking CHEK2. JAMA Oncol. 8, 1598 (2022).","journal-title":"JAMA Oncol."},{"key":"71884_CR22","unstructured":"National Comprehensive Cancer Network. Pancreatic Adenocarcinoma 1\u2013174 (2023)."},{"key":"71884_CR23","first-page":"66","volume":"11","author":"H Jiang","year":"2023","unstructured":"Jiang, H. et al. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Mol. Genet. Genom. Med. 11, 66 (2023).","journal-title":"Mol. Genet. Genom. Med."},{"key":"71884_CR24","first-page":"58","volume":"7","author":"I Tzfoni","year":"2019","unstructured":"Tzfoni, I. et al. Pancreatic cancer in bloom syndrome. SAGE Open Med. Case Rep. 7, 58 (2019).","journal-title":"SAGE Open Med. Case Rep."},{"key":"71884_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.canlet.2015.10.030","volume":"370","author":"AL Smith","year":"2016","unstructured":"Smith, A. L. et al. Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer. Cancer Lett. 370, 302\u2013312 (2016).","journal-title":"Cancer Lett."},{"key":"71884_CR26","doi-asserted-by":"publisher","first-page":"e16276","DOI":"10.1200\/JCO.2023.41.16_suppl.e16276","volume":"41","author":"N Tsoulos","year":"2023","unstructured":"Tsoulos, N. et al. Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes. J. Clin. Oncol. 41, e16276\u2013e16276 (2023).","journal-title":"J. Clin. Oncol."},{"key":"71884_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12929-024-01008-7","volume":"31","author":"SM Cheng","year":"2024","unstructured":"Cheng, S. M. et al. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan. J. Biomed. Sci. 31, 21 (2024).","journal-title":"J. Biomed. Sci."},{"key":"71884_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35066","author":"B Stastna","year":"2024","unstructured":"Stastna, B. et al. Germline pathogenic variants in the MRE11, RAD50, and NBN (MRN) genes in cancer predisposition: A systematic review and meta-analysis. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.35066 (2024).","journal-title":"Int. J. Cancer"},{"key":"71884_CR29","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos, F. et al. Risk of pancreatic cancer in families with lynch syndrome. JAMA 302, 1790 (2009).","journal-title":"JAMA"},{"key":"71884_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ijc.29149","volume":"136","author":"C Kraus","year":"2015","unstructured":"Kraus, C. et al. Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations. Int. J. Cancer 136, 66 (2015).","journal-title":"Int. J. Cancer"},{"key":"71884_CR31","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00443","author":"EE Salo-Mullen","year":"2021","unstructured":"Salo-Mullen, E. E. et al. Prevalence and characterization of Biallelic and Monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/PO.20.00443 (2021).","journal-title":"JCO Precis. Oncol."},{"key":"71884_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15252\/embj.201693860","volume":"35","author":"J Michl","year":"2016","unstructured":"Michl, J., Zimmer, J. & Tarsounas, M. Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J. 35, 909\u2013923 (2016).","journal-title":"EMBO J."},{"key":"71884_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/gim.2017.124","volume":"20","author":"M Bogliolo","year":"2018","unstructured":"Bogliolo, M. et al. Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia. Genet. Med. 20, 458\u2013463 (2018).","journal-title":"Genet. Med."},{"key":"71884_CR34","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.1407909111","volume":"111","author":"JI Kiiski","year":"2014","unstructured":"Kiiski, J. I. et al. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc. Natl. Acad. Sci. 111, 15172\u201315177 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"71884_CR35","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/ijc.31992","volume":"144","author":"S Schubert","year":"2019","unstructured":"Schubert, S. et al. The identification of pathogenic variants in BRCA1\/2 negative, high risk, hereditary breast and\/or ovarian cancer patients: High frequency of FANCM pathogenic variants. Int. J. Cancer 144, 2683\u20132694 (2019).","journal-title":"Int. J. Cancer"},{"key":"71884_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.48721","volume":"5","author":"L Yin","year":"2022","unstructured":"Yin, L. et al. Prevalence of germline sequence variations among patients with pancreatic cancer in China. JAMA Netw. Open 5, e2148721 (2022).","journal-title":"JAMA Netw. Open"},{"key":"71884_CR37","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/nar\/gkm033","volume":"35","author":"RK Nookala","year":"2007","unstructured":"Nookala, R. K., Hussain, S. & Pellegrini, L. Insights into Fanconi anaemia from the structure of human FANCE. Nucleic Acids Res. 35, 1638\u20131648 (2007).","journal-title":"Nucleic Acids Res."},{"key":"71884_CR38","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","volume":"126","author":"JE Churpek","year":"2015","unstructured":"Churpek, J. E. et al. Genomic analysis of germ line and somatic variants in familial myelodysplasia\/acute myeloid leukemia. Blood 126, 2484\u20132490 (2015).","journal-title":"Blood"},{"key":"71884_CR39","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1158\/1078-0432.CCR-19-0224","volume":"26","author":"JB Goldstein","year":"2020","unstructured":"Goldstein, J. B. et al. Germline DNA sequencing reveals novel mutations predictive of overall survival in a cohort of patients with pancreatic cancer. Clin. Cancer Res. 26, 1385\u20131394 (2020).","journal-title":"Clin. Cancer Res."},{"key":"71884_CR40","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3390\/cancers12082151","volume":"12","author":"C Vel\u00e1zquez","year":"2020","unstructured":"Vel\u00e1zquez, C. et al. Germline genetic findings which may impact therapeutic decisions in families with a presumed predisposition for hereditary breast and ovarian cancer. Cancers 12, 2151 (2020).","journal-title":"Cancers"},{"key":"71884_CR41","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/humu.22438","volume":"34","author":"A Osorio","year":"2013","unstructured":"Osorio, A. et al. Evaluation of rare variants in the new Fanconi Anemia Gene ERCC4 (FANCQ ) as familial breast\/ovarian cancer susceptibility alleles. Hum. Mutat. 34, 1615\u20131618 (2013).","journal-title":"Hum. Mutat."},{"key":"71884_CR42","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/ijc.25870","volume":"129","author":"AK Win","year":"2011","unstructured":"Win, A. K. et al. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int. J. Cancer 129, 2256\u20132262 (2011).","journal-title":"Int. J. Cancer"},{"key":"71884_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10549-012-1965-0","volume":"134","author":"AA Out","year":"2012","unstructured":"Out, A. A. et al. MUTYH gene variants and breast cancer in a Dutch case\u2013control study. Breast Cancer Res. Treat. 134, 219\u2013227 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"71884_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/ijo.2014.2410","volume":"45","author":"A Rohlin","year":"2014","unstructured":"Rohlin, A. et al. A mutation in POLE predisposing to a multi-tumour phenotype. Int. J. Oncol. 45, 77\u201381 (2014).","journal-title":"Int. J. Oncol."},{"key":"71884_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10689-015-9803-2","volume":"14","author":"MF Hansen","year":"2015","unstructured":"Hansen, M. F. et al. A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine. Fam. Cancer 14, 437\u2013448 (2015).","journal-title":"Fam. Cancer"},{"key":"71884_CR46","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00267","author":"B Garmezy","year":"2022","unstructured":"Garmezy, B. et al. Clinical and molecular characterization of POLE mutations as predictive biomarkers of response to immune checkpoint inhibitors in advanced cancers. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/PO.21.00267 (2022).","journal-title":"JCO Precis. Oncol."},{"key":"71884_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature10539","volume":"480","author":"C Bertolotto","year":"2011","unstructured":"Bertolotto, C. et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480, 94\u201398 (2011).","journal-title":"Nature"},{"key":"71884_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/pcmr.12047","volume":"26","author":"P Ghiorzo","year":"2013","unstructured":"Ghiorzo, P. et al. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell Melanoma Res. 26, 259\u2013262 (2013).","journal-title":"Pigment Cell Melanoma Res."},{"key":"71884_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature10630","volume":"480","author":"S Yokoyama","year":"2011","unstructured":"Yokoyama, S. et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480, 99\u2013103 (2011).","journal-title":"Nature"},{"key":"71884_CR50","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon, N. et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 19, 3011\u20133020 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"71884_CR51","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/cancers12041007","volume":"12","author":"L Pastorino","year":"2020","unstructured":"Pastorino, L. et al. Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in ACD, ATM, BAP1, and POT1. Cancers 12, 1007 (2020).","journal-title":"Cancers"},{"key":"71884_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/jnci\/dju408","volume":"107","author":"LG Aoude","year":"2015","unstructured":"Aoude, L. G. et al. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. J. Natl. Cancer Inst. 107, 66 (2015).","journal-title":"J. Natl. Cancer Inst."},{"key":"71884_CR53","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/humu.23549","volume":"39","author":"DR Evans","year":"2018","unstructured":"Evans, D. R. et al. Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer. Hum. Mutat. 39, 1092\u20131101 (2018).","journal-title":"Hum. Mutat."},{"key":"71884_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"71884_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","volume":"11","author":"M Riester","year":"2016","unstructured":"Riester, M. et al. PureCN: Copy number calling and SNV classification using targeted short read sequencing. Source Code Biol. Med. 11, 13 (2016).","journal-title":"Source Code Biol. Med."},{"key":"71884_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.abl9283","volume":"376","author":"A Degasperi","year":"2022","unstructured":"Degasperi, A. et al. Substitution mutational signatures in whole-genome\u2013sequenced cancers in the UK population. Science 376, 66 (2022).","journal-title":"Science"},{"key":"71884_CR57","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"71884_CR58","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s42003-020-01119-5","volume":"3","author":"VK Singh","year":"2020","unstructured":"Singh, V. K., Rastogi, A., Hu, X., Wang, Y. & De, S. Mutational signature SBS8 predominantly arises due to late replication errors in cancer. Commun. Biol. 3, 421 (2020).","journal-title":"Commun. Biol."},{"key":"71884_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fonc.2020.00145","volume":"10","author":"RO Dur\u00e3es","year":"2020","unstructured":"Dur\u00e3es, R. O. et al. Role of genetic ancestry in 1,002 Brazilian colorectal cancer patients from Barretos Cancer Hospital. Front. Oncol. 10, 66 (2020).","journal-title":"Front. Oncol."},{"key":"71884_CR60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.clbc.2023.04.001","volume":"23","author":"RA da Costa Vieira","year":"2023","unstructured":"da Costa Vieira, R. A. et al. Genetic ancestry of 1127 Brazilian breast cancer patients and its correlation with molecular subtype and geographic region. Clin. Breast Cancer 23, 527\u2013537 (2023).","journal-title":"Clin. Breast Cancer"},{"key":"71884_CR61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41436-018-0009-5","volume":"21","author":"MB Yurgelun","year":"2019","unstructured":"Yurgelun, M. B. et al. Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genet. Med. 21, 213\u2013223 (2019).","journal-title":"Genet. Med."},{"key":"71884_CR62","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.21037\/jgo.2019.09.12","volume":"10","author":"S Palacio","year":"2019","unstructured":"Palacio, S. et al. DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer. J. Gastrointest. Oncol. 10, 1133\u20131139 (2019).","journal-title":"J. Gastrointest. Oncol."},{"key":"71884_CR63","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00115","author":"MJ Pishvaian","year":"2019","unstructured":"Pishvaian, M. J. et al. Outcomes in patients with pancreatic adenocarcinoma with genetic mutations in DNA damage response pathways: Results from the know your tumor program. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/PO.19.00115 (2019).","journal-title":"JCO Precis. Oncol."},{"key":"71884_CR64","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.1158\/1078-0432.CCR-18-1472","volume":"24","author":"A Sehdev","year":"2018","unstructured":"Sehdev, A. et al. Germline and somatic DNA damage repair gene mutations and overall survival in metastatic pancreatic adenocarcinoma patients treated with FOLFIRINOX. Clin. Cancer Res. 24, 6204\u20136211 (2018).","journal-title":"Clin. Cancer Res."},{"key":"71884_CR65","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1002\/cncr.31628","volume":"124","author":"R Brand","year":"2018","unstructured":"Brand, R. et al. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma. Cancer 124, 3520\u20133527 (2018).","journal-title":"Cancer"},{"key":"71884_CR66","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fonc.2019.01429","volume":"9","author":"J Oliver","year":"2019","unstructured":"Oliver, J. et al. Latin American study of hereditary breast and ovarian cancer LACAM: A genomic epidemiology approach. Front. Oncol. 9, 66 (2019).","journal-title":"Front. Oncol."},{"key":"71884_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247363","volume":"16","author":"RL Sandoval","year":"2021","unstructured":"Sandoval, R. L. et al. Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis. PLoS ONE 16, e0247363 (2021).","journal-title":"PLoS ONE"},{"key":"71884_CR68","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00432-018-2763-9","volume":"144","author":"S Bonache","year":"2018","unstructured":"Bonache, S. et al. Multigene panel testing beyond BRCA1\/2 in breast\/ovarian cancer Spanish families and clinical actionability of findings. J. Cancer Res. Clin. Oncol. 144, 2495\u20132513 (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"71884_CR69","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1038\/s41436-019-0541-y","volume":"21","author":"HQ Rana","year":"2019","unstructured":"Rana, H. Q. et al. Genotype\u2013phenotype associations among panel-based TP53+ subjects. Genet. Med. 21, 2478\u20132484 (2019).","journal-title":"Genet. Med."},{"key":"71884_CR70","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a003210","volume":"5","author":"M Swaminathan","year":"2019","unstructured":"Swaminathan, M. et al. Hematologic malignancies and Li\u2013Fraumeni syndrome. Mol. Case Stud. 5, a003210 (2019).","journal-title":"Mol. Case Stud."},{"key":"71884_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10689-017-9998-5","volume":"17","author":"RC Andrade","year":"2018","unstructured":"Andrade, R. C., de Lima, M. A. F. D., de Faria, P. A. S. & Vargas, F. R. TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma. Fam. Cancer 17, 119\u2013122 (2018).","journal-title":"Fam. Cancer"},{"key":"71884_CR72","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.clml.2016.04.001","volume":"16","author":"CD DiNardo","year":"2016","unstructured":"DiNardo, C. D. et al. Evaluation of patients and families with concern for predispositions to hematologic malignancies within the Hereditary Hematologic Malignancy Clinic (HHMC). Clin. Lymphoma Myeloma Leuk. 16, 417-428.e2 (2016).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"71884_CR73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/SLA.0b013e3180691579","volume":"246","author":"KY Bilimoria","year":"2007","unstructured":"Bilimoria, K. Y. et al. National failure to operate on early stage pancreatic cancer. Ann. Surg. 246, 173\u2013180 (2007).","journal-title":"Ann. Surg."},{"key":"71884_CR74","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.3390\/cancers14194672","volume":"14","author":"H Kang","year":"2022","unstructured":"Kang, H. et al. Evaluation of the 8th Edition AJCC staging system for the clinical staging of pancreatic cancer. Cancers 14, 4672 (2022).","journal-title":"Cancers"},{"key":"71884_CR75","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/SLA.0000000000001763","volume":"265","author":"PJ Allen","year":"2017","unstructured":"Allen, P. J. et al. Multi-institutional validation study of the American Joint Commission on Cancer (8th Edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann. Surg. 265, 185\u2013191 (2017).","journal-title":"Ann. Surg."},{"key":"71884_CR76","unstructured":"IBGE Educa Jovens. Conhe\u00e7a o Brasil\u2014Popula\u00e7\u00e3o COR OU RA\u00c7A. https:\/\/educa.ibge.gov.br\/jovens\/conheca-o-brasil\/populacao\/18319-cor-ou-raca.html%20 (2024)."},{"key":"71884_CR77","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1186\/s12885-016-2966-x","volume":"16","author":"S Maistro","year":"2016","unstructured":"Maistro, S. et al. Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil. BMC Cancer 16, 934 (2016).","journal-title":"BMC Cancer"},{"key":"71884_CR78","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s10120-019-00945-9","volume":"22","author":"RSC Guindalini","year":"2019","unstructured":"Guindalini, R. S. C. et al. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil. Gastric Cancer 22, 920\u2013931 (2019).","journal-title":"Gastric Cancer"},{"key":"71884_CR79","unstructured":"Center for Disease Control and Prevention. Alcohol Basics\u2014Alcohol Questions and Answers. https:\/\/www.cdc.gov\/alcohol\/faqs.htm#heavyDrinking (2022)."},{"key":"71884_CR80","unstructured":"National Institute on Alcohol Abuse and Alcoholism (NIAAA). What Is A Standard Drink? National Institute on Alcohol Abuse and Alcoholism (NIAAA) https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/overview-alcohol-consumption\/what-standard-drink."},{"key":"71884_CR81","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.3390\/ijerph10094186","volume":"10","author":"T Neumann","year":"2013","unstructured":"Neumann, T., Rasmussen, M., Heitmann, B. & T\u00f8nnesen, H. Gold standard program for heavy smokers in a real-life setting. Int. J. Environ. Res. Public Health 10, 4186\u20134199 (2013).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"71884_CR82","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"71884_CR83","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"71884_CR84","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41436-019-0475-4","volume":"21","author":"T Chiang","year":"2019","unstructured":"Chiang, T. et al. Atlas-CNV: A validated approach to call single-exon CNVs in the eMERGESeq gene panel. Genet. Med. 21, 2135\u20132144 (2019).","journal-title":"Genet. Med."},{"key":"71884_CR85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fonc.2020.571330","volume":"10","author":"RS Grasel","year":"2020","unstructured":"Grasel, R. S. et al. Using co-segregation and loss of heterozygosity analysis to define the pathogenicity of unclassified variants in hereditary breast cancer patients. Front. Oncol. 10, 66 (2020).","journal-title":"Front. Oncol."},{"key":"71884_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029684","volume":"7","author":"R Pereira","year":"2012","unstructured":"Pereira, R. et al. Straightforward inference of ancestry and admixture proportions through ancestry-informative insertion deletion multiplexing. PLoS ONE 7, e29684 (2012).","journal-title":"PLoS ONE"},{"key":"71884_CR87","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/cncr.31242","volume":"124","author":"B Dudley","year":"2018","unstructured":"Dudley, B. et al. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy. Cancer 124, 66 (2018).","journal-title":"Cancer"},{"key":"71884_CR88","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/1055-9965.EPI-15-0455","volume":"25","author":"C Hu","year":"2016","unstructured":"Hu, C. et al. Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients. Cancer Epidemiol. Biomarkers Prev. 25, 66 (2016).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"71884_CR89","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1101\/mcs.a003681","volume":"5","author":"ML Thibodeau","year":"2019","unstructured":"Thibodeau, M. L. et al. Base excision repair deficiency signatures implicate germline and somatic MUTYH aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis. Cold Spring Harb. Mol. Case Stud. 5, 66 (2019).","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"71884_CR90","first-page":"66","volume":"6","author":"F Xie","year":"2022","unstructured":"Xie, F. et al. RAD51B harbors germline mutations associated with pancreatic ductal adenocarcinoma. JCO Precis. Oncol. 6, 66 (2022).","journal-title":"JCO Precis. Oncol."},{"key":"71884_CR91","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1210\/jc.2017-01762","volume":"103","author":"K van der Tuin","year":"2018","unstructured":"van der Tuin, K. et al. Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: A nationwide study. J. Clin. Endocrinol. Metab. 103, 438\u2013445 (2018).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71884-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71884-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71884-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:19:48Z","timestamp":1726244388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71884-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71884"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71884-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RSCG declares Stock and Other Ownership Interests: Mendelics An\u00e1lise Gen\u00f4mica; Consulting or Advisory Role: AstraZeneca, MSD; Speakers\u2019 Bureau: AstraZeneca, Roche, Gilead, GSK, MSD, BMS, Novartis, Pfizer, Daiichi Sankyo; Travel, Accommodations, Expense, Dais: AstraZeneca, Gilead, Daiichi Sankyo. All other authors do not have any conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21083"}}